about
P361
Cystic fibrosis transmembrane conductance regulatorSynaptotagmin like 2Sec1 family domain containing 1Potassium voltage-gated channel subfamily B member 1RAB3A, member RAS oncogene familyRAB8A, member RAS oncogene familyVPS11 core subunit of CORVET and HOPS complexesRAB26, member RAS oncogene familyComplexin 2Vesicle transport through interaction with t-SNAREs 1BRAB37, member RAS oncogene familyVPS18 core subunit of CORVET and HOPS complexesSec1 family domain containing 2RAB10, member RAS oncogene familySyntaxin 1BSyntaxin binding protein 2RAB40A likeRAB40B, member RAS oncogene familyRAB40C, member RAS oncogene familyVacuolar protein sorting 45 homologVPS33A core subunit of CORVET and HOPS complexesRAB15, member RAS oncogene familyRAB8B, member RAS oncogene familyVesicle associated membrane protein 3Syntaxin binding protein 3RAB3D, member RAS oncogene familyRAB3B, member RAS oncogene familyRAB3C, member RAS oncogene familyVPS33B late endosome and lysosome associatedYKT6 v-SNARE homologSyntaxin-binding protein 2Syntaxin-binding protein 1Exocyst complex component 4Exocyst complex component 6BExocyst complex component 6Syntaxin binding protein 1Rab9 effector protein with kelch motifsRAB40A, member RAS oncogene familyExocyst complex component 4Exocyst complex component 6
P682
Complexins: cytosolic proteins that regulate SNAP receptor functionYkt6p, a prenylated SNARE essential for endoplasmic reticulum-Golgi transportA novel Rab9 effector required for endosome-to-TGN transportRegulation of synaptic vesicle docking by different classes of macromolecules in active zone material
P921
Q14864718-11DC4354-A0E7-4AEB-84E5-62BB77AD5AC3Q15320766-0742C2DB-E9F5-4284-AC32-12D6F815E666Q21106815-744434AD-D9E7-4DEF-B475-66836B2A4C26Q21107884-77AC7F9C-01F0-47DF-8CB5-74B7452AA52AQ21108063-2DB2C5EF-BE5A-42FA-BBE4-2ED7DC2EC632Q21108073-1CEDB92B-498B-4BD2-8270-08A0527100B5Q21108073-3B8F3EF6-5251-42E0-84A5-BF9EFAC7B096Q21109619-C26F3BC1-0839-4285-BFE7-E7907E570240Q21113774-B6A12B21-21AB-4D45-AECC-DE5F7EFF86E1Q21115695-5DFFA870-B172-4194-9F69-F4527E591B0BQ21120732-F1903688-CB06-4418-90A5-7234F676F7C9Q21120820-EF1A3AD5-A7F9-41AA-A4CF-E513D42F547DQ21122402-245BA57A-81EE-49DC-8C2B-BF38CD1D8D46Q21122776-B35EDBCD-0A69-48CB-A9C0-C2F893101EDFQ21123657-CE5B0D2A-062E-4452-AC73-F457DEDFCA31Q21123908-8477FB72-2263-4172-8F91-58C242A94D31Q21123912-1133B1F8-EE55-4529-92CA-2E27B2451F6BQ21125014-115D15C8-7579-4A36-81AF-35B828560EB6Q21125017-8614CB74-0D60-4630-8684-14C50B39404EQ21125025-F970A2EE-1149-4899-8167-43FB81574955Q21125050-810CA112-F75C-44A5-BFC4-1E824775C194Q21125656-5B0CB9F5-70B2-4BAE-870E-F616C81A4FC2Q21126072-8320D49E-86FA-4EA7-A02D-1F3E02EC76C5Q21126901-36DC5CAD-159E-4826-A438-B2249A2EDF77Q21131168-6A68B804-EBD0-457F-BB60-BB9A823E4A8FQ21134413-50F61553-93E0-44EF-AAD7-C5CA4D71E0A0Q21135208-3937D784-653A-46DB-8D5D-BC6383C824B3Q21135210-9B5D3347-C999-411A-9B3C-7CB4A1765F0EQ21135247-1B69762E-5F0C-4F9E-9A0C-49BFC7058482Q21135669-D4BB3BBB-984B-4475-B992-9E4191B15FF9Q21136776-A67FA0BA-C4BB-4C65-A88B-AAA38AF80A80Q21139244-F7AC1880-6F09-445D-8421-B590EB7D252BQ21146018-5EBC14D8-E9F2-4888-87EA-9185D9045BADQ21173289-FD3C4C33-9BA6-49CB-A22B-A98BB214FF87Q21173313-94A0E948-2751-4A17-8D27-7BB750037643Q21173707-6777F1C3-721C-4508-9DB2-D6795F07FED9Q21174816-74BB3849-529B-439D-ADC2-61AFBCF56120Q21202220-6160FB59-D148-494E-83BB-DFD5CEECFD46Q21207959-2D0053A2-684F-43CB-9245-7FECFC776930Q21494406-B84EFD8B-B016-492E-8789-A682CEEBB70F
P682
description
The initial attachment of a ve ...... hat contributes to exocytosis.
@en
biologisch proces
@nl
name
vesicle docking involved in exocytosis
@en
type
label
vesicle docking involved in exocytosis
@en
altLabel
GO:0006904
@en
prefLabel
vesicle docking involved in exocytosis
@en
P2888
P686
GO:0006904